Ramasastry Saira

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
14
Insider Sells Sum
$2.2M

Insider Activity of Ramasastry Saira

According to the SEC Form 4 filings, Ramasastry Saira, being in a position of

  1. director at Day One Biopharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 10000 shares for $131,877,
    over all time since 2024-06-21, has bought 0 shares, and sold 10000 shares for $131,877.

The largest sale of all time was on 2021-05-19 and amounted to 20000 shares of Vir Biotechnology, Inc. for $564,875.

Biography of Ramasastry Saira

No biography is available at this moment.

2024-06-21SaleDay One Biopharmaceuticals, Inc.
DAWN
director
10,000
0.012%
$13.19$131,877+1.75%
2024-06-11SaleVir Biotechnology, Inc.
VIR
director
4,000
0.003%
$10.95$43,789-23.8%
2024-06-05SaleMirum Pharmaceuticals, Inc.
MIRM
director
5,000
0.0104%
$25.68$128,400+53.65%
2023-06-01SaleVir Biotechnology, Inc.
VIR
director
3,500
0.0025%
$25.67$89,845-62.68%
2022-07-11SaleVir Biotechnology, Inc.
VIR
5,000
0.0038%
$30.00$150,000-16.42%
2022-05-23SaleVir Biotechnology, Inc.
VIR
1,687
0.0013%
$23.82$40,184+3.98%
2021-05-19SaleVir Biotechnology, Inc.
VIR
director
20,000
0.0099%
$28.24$564,875-15.78%
2020-12-17SaleSangamo Therapeutics, Inc.
SGMO
director
10,000
0.0074%
$13.27$132,747-19.51%
2018-02-26SaleSangamo Therapeutics, Inc.
SGMO
director
9,450
0.0109%
$24.88$235,080-40.48%
2017-11-17SaleSangamo Therapeutics, Inc.
SGMO
director
5,000
0.0059%
$14.67$73,339+10.05%
2015-02-12SaleSangamo Therapeutics, Inc.
SGMO
director
10,000
0.0142%
$15.00$150,000-39.74%
2014-08-08SaleSangamo Therapeutics, Inc.
SGMO
director
10,000
0.0149%
$14.00$140,000-8.77%
2014-06-23SaleSangamo Therapeutics, Inc.
SGMO
director
5,550
0.0082%
$15.53$86,217-15.5%
2014-03-17SaleSangamo Therapeutics, Inc.
SGMO
director
10,000
0.016%
$23.26$232,608-41.23%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.